Automate Your Wheel Strategy on CAH
With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Why Cardinal Health May Be a Best Buy for the Coming Stagflation
Published: March 06, 2026 by: 24/7 Wall Street
Sentiment: Negative
This morning's jobs report landed hard.
Read More
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
Published: March 05, 2026 by: Zacks Investment Research
Sentiment: Positive
CAH shares have surged 49% in six months as strong pharma distribution, expanding specialty services and fast-growing adjacencies fuel Cardinal Health???s earnings outlook.
Read More
Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?
Published: March 05, 2026 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Published: March 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Published: March 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: March 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Best Dividend Aristocrats For March 2026
Published: February 27, 2026 by: Seeking Alpha
Sentiment: Positive
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) is up 9.39% YTD in 2026, decisively outperforming SPY's 1.08%. Dividend Aristocrats are regaining momentum after a weak 2025, with 55 outpacing SPY and 39 posting double-digit gains this year already. Dividend growth is lagging, with 2026's average increase currently at 3.22%, below last year's trend and potentially signaling headwinds.
Read More
3 Big Winners from the 2025 Q4 Earnings Cycle: CAH, BOOT, PLTR
Published: February 26, 2026 by: Zacks Investment Research
Sentiment: Positive
The 2025 Q4 earnings season is pretty much over following the highly-awaited NVIDIA release. Throughout the period, these three releases have stood out.
Read More
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
Published: February 17, 2026 by: Zacks Investment Research
Sentiment: Neutral
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Best Momentum Stock to Buy for February 13th
Published: February 13, 2026 by: Zacks Investment Research
Sentiment: Positive
LTM, ING and CAH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 13, 2026.
Read More
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Published: February 13, 2026 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Published: February 12, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Here's Why Cardinal Health (CAH) is a Strong Momentum Stock
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
The $65.6 Billion Secret Wall Street Doesn't Want You to Know About Cardinal Health
Published: February 05, 2026 by: 24/7 Wall Street
Sentiment: Positive
Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%.
Read More
CAH Q2 Earnings Beat Estimates, '26 EPS View Up, Stock Gains
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Positive
CAH tops second-quarter fiscal 2026 EPS estimates by 10%, posts strong segment profits, and raises full-year earnings outlook, sending shares higher.
Read More
Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.
Published: February 05, 2026 by: Barrons
Sentiment: Positive
The pharmaceutical distributor and health services company raises its guidance for the second time.
Read More
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
Published: February 05, 2026 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript
Read More
Compared to Estimates, Cardinal (CAH) Q2 Earnings: A Look at Key Metrics
Published: February 05, 2026 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Pharma, Specialty Units Likely to Drive Cardinal Health's Q2 Earnings
Published: February 04, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.
Read More
Cardinal Health, Inc. (CAH) Hits Fresh High: Is There Still Room to Run?
Published: February 03, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Cardinal (CAH) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
4 Defensive Stocks to Buy as Consumer Confidence Dips to12-Year Low
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
With consumer confidence at a 12-year low, low-beta picks AEE, FTS, CAH and JJSF stand out as defensive plays to weather volatility.
Read More
4 Stocks With Strong Coverage Ratios to Buy in a Tight Market
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
CASY, CAH, EAT and FLS stand out with strong interest coverage ratios as investors seek stability in a tighter market.
Read More
5 Broker-Loved Stocks to Watch Amid Steady Start to Q4 Earnings Season
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive
As inflation cools and Q4 earnings season shows strength, brokers back stocks like CAH, AN, TGT, AVT and ABM for potential upside.
Read More
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: January 29, 2026 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Is Cardinal Health (CAH) Stock Undervalued Right Now?
Published: January 28, 2026 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Cardinal Health (CAH) is a Strong Growth Stock
Published: January 27, 2026 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
Published: January 23, 2026 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
About Cardinal Health, Inc. (CAH)
- IPO Date 1983-08-04
- Website https://www.cardinalhealth.com
- Industry Medical - Distribution
- CEO Jason Hollar
- Employees 47922